Mirum Pharmaceuticals (MIRM) Current Assets (2018 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Current Assets of $569.4 million for Q1 2026, up 38.61% year-over-year from $410.8 million in Q1 2025, and up 3.59% quarter-over-quarter from $549.7 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Current Assets (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Current Assets history runs 9 years deep, the most recent figure standing at $569.4 million for Q1 2026.
- In Q1 2026, Current Assets rose 38.61% year-over-year to $569.4 million; the TTM figure through Mar 2026 stood at $569.4 million (up 38.61% YoY), while the FY2025 annual figure was $549.7 million, up 39.94% from the prior year.
- Current Assets for Q1 2026 stood at $569.4 million, up from $549.7 million in the prior quarter.
- The five-year high for Current Assets was $569.4 million in Q1 2026, with the low at $147.2 million in Q2 2022.
- The 5-year median for Current Assets is $387.5 million (2023), against an average of $358.3 million.
- The sharpest annual moves came in 2022 and 2023: Current Assets tumbled 35.52% in 2022, then surged 160.46% in 2023.
- Mirum Pharmaceuticals' Current Assets stood at $190.2 million in 2022, then jumped by 103.73% to $387.5 million in 2023, then increased by 1.35% to $392.8 million in 2024, then soared by 39.94% to $549.7 million in 2025, then increased by 3.59% to $569.4 million in 2026.
- Business Quant data shows MIRM's Current Assets at $569.4 million in Q1 2026, $549.7 million in Q4 2025, and $530.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 636.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 636.31 Mn |
| Mar 31, 2026 | 569.44 Mn |
| Dec 31, 2025 | 549.68 Mn |
| Sep 30, 2025 | 530.58 Mn |
| Jun 30, 2025 | 453.40 Mn |
| Mar 31, 2025 | 410.82 Mn |
| Dec 31, 2024 | 392.79 Mn |
| Sep 30, 2024 | 386.63 Mn |
| Jun 30, 2024 | 367.83 Mn |
| Mar 31, 2024 | 389.47 Mn |
| Dec 31, 2023 | 387.54 Mn |
| Sep 30, 2023 | 388.58 Mn |
| Jun 30, 2023 | 383.52 Mn |
| Mar 31, 2023 | 172.33 Mn |
| Dec 31, 2022 | 190.23 Mn |
| Sep 30, 2022 | 215.56 Mn |
| Jun 30, 2022 | 147.25 Mn |
| Mar 31, 2022 | 155.27 Mn |
| Dec 31, 2021 | 166.59 Mn |
| Sep 30, 2021 | 196.81 Mn |